Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Visa Inc (V) Price & Performance

Elanco Animal Health Incorporated Common StockTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs Visa Inc — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.69 (market cap $11.26B), while Visa Inc trades at $374 (market cap $704.20B). The key difference: Visa Inc is far larger — about 62.5× Elanco Animal Health Incorporated Common Stock's market cap, and Visa Inc pays a 0.71% dividend while Elanco Animal Health Incorporated Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Visa Inc for 115 Days on average.

ELANV
Market Cap
$11.26B$704.20B
Volume
4,570,3866,405,857
Sector
HealthFinancials
52-Week High
$26.84$384.14
52-Week Low
$19.76$295.52
Typical Hold Time
0 Days115 Days
Enterprise Value
$14.65B$714.78B
Dividend Yield
—0.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

Visa Inc

Visa (V) trades at $372.10, up 0.39% with strong bullish technical momentum. The company demonstrates robust fundamentals with 2025 revenue of $40B and net income margin of 50.78%. Recent earnings beats and a consensus price target of $422.24 reflect Wall Street optimism. Visa's expansion into AI-powered commerce through Intelligent Commerce Connect positions it for future growth while maintaining exceptional profitability metrics including 61.79% ROE.

Visa presents a compelling investment case with consistent earnings outperformance and dominant market position. Key opportunities include AI integration and stablecoin partnerships, while risks involve regulatory scrutiny and fintech competition. With 85% analyst buy ratings and 13% upside to consensus target, the stock offers growth potential despite premium valuation multiples.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
V
39% Buy61% Sell
Avg holding period · 115 Days

Top news

Latest headlines on both assets

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About Visa Inc

Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.

Read more on V →